Mohammad Ali Omrani

10PUBLICATIONS
5CO-AUTHORS
Epidemiological modellingBehavioural epidemiologyRespiratory diseasesAdversarial machine learningMedicinal and biomolecular chemistry not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 13, 2026
Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

|Mar 06, 2026
Fluoroquinolones and the risk of panic attacks: a systematic review and disproportionality analysis using individual case safety reports from the FDA Adverse Event Reporting System (FAERS) database.

Keeirah Hiertika Raguram, Manroop Sidhu, Mohammad Ali Omrani

|Jan 20, 2026
Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review.

Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T Muanda

|Dec 05, 2025
Machine learning methods for predicting adverse drug events: A systematic review.

Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani

|Sep 25, 2025
Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment.

Niaz Chalabianloo, Sheikh S Abdullah, Mohammad Ali Omrani

|Jul 24, 2025
β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS.

Lujain Ez Eddin, Mohammad Ali Omrani, Niaz Chalabianloo

Pageof 2

Frequent Collaborators

9 joint publications

Flory Tsobo Muanda

1 joint publications

Niaz Chalabianloo

1 joint publications

Sheikh S Abdullah

1 joint publications

Atefeh Jafari